, APAC
299 views

UN urges stronger COVAX support for APAC

The international organisation is calling for countries with surplus COVID-19 vaccine doses to donate to COVAX.

The United Nation’s (UN) refugee agency has urged for an “immediate and stronger support” for the global COVAX initiative for equitable access to COVID-19 vaccines, amidst vaccine shortages especially in the Asia-Pacific region, according to a news release.

Although Asia-Pacific countries host the vast majority of more than 80 million forcibly displaced people around the globe, they have benefited from only a fraction of the world’s COVID-19 innoculations, the United Nations High Commissioner for Refugees (UNHCR) said.

“UNHCR is adding its voice to the calls for countries with surplus doses to donate to COVAX, and for manufacturers to boost supplies to the COVAX facility”, said Mr. Mahecic.

Included in its regular budget, UNHCR’s total financial requirements for COVID include $455m in supplementary needs and $469m in COVID-related activities. To date, including projected contributions, UNHCR has received $252.8m or only 27% of these requirements.

Concern over the situation in the region continues to rise as the number of cases has surged to the largest increase globally. UNHCR stressed that the pandemic will only be defeated when vaccinations are available everywhere “on an equitable basis.”

Some 38 million COVID-19 cases have been recorded along with more than half a million deaths. “The lack of hospital beds, oxygen supplies, limited intensive care unit (ICU) capacities and scarce health facilities and services have worsened outcomes for those infected with COVID-19, particularly in India and Nepal,” said UNHCR spokesperson Andrej Mahecic.

Amidst overcrowded settings, limited water and lack of sanitation facilities, refugees remained at risk of COVID-19. Mahecic noted that there has been a rise in cases amongst refugees and asylum-seekers in Bangladesh, Nepal, Iran, Pakistan, Thailand, Malaysia and Indonesia.

Although some refugees, including in Nepal, have received their first jab with COVAX-provided supplies, not a single vaccine has been administered to Rohingya refugees in Bangladesh, rendering them susceptible to the virus, UNHCR noted.
 

Since you're here...

...there are many ways you can work with us to advertise your company and connect to your customers. Our team can help you dight and create an advertising campaign, in print and digital, on this website and in print magazine.

We can also organize a real life or digital event for you and find thought leader speakers as well as industry leaders, who could be your potential partners, to join the event. We also run some awards programmes which give you an opportunity to be recognized for your achievements during the year and you can join this as a participant or a sponsor.

Let us help you drive your business forward with a good partnership!

Get Health Care Asia Magazine in your inbox
It was recognised for its cutting-edge medical device packaging design, Dispenser Integrated System Kit (DISK).
There has been an expanding research base across India, China, and Japan.
It combines third-party assured data verification with blockchain technology.
Consultation is available for only $0.014 (INR1).
The number of hospitals operating on hip fracture that have access to a fracture liaison service has been steadily rising from 2013 to 2020.
GMT Manila’s award-winning initiative, in collaboration with Endec Inc. and Scilore LLC, is a rapidly deployable turnkey solution for RT-PCR Testing that made it more available across the Philippines. 
As The National Cardiovascular Referral Center in Indonesia, NCCHK has been acknowledged by Asia's Healthcare Industry.
Currently, North America dominates the market across the globe.
More medical devices are being bought for home use.
It has also introduced a new hotline service.
The firm was recognised for its multiple initiatives in braving the COVID-19 crisis.
It took home the Training Initiative of the Year trophy for its non-invasive therapy treatment for benign prostatic hyperplasia (BPH).
The country’s SII makes up about half of Covax supply.
It owns 39 hospitals and eight clinics across England, Wales, and Scotland.
The company plans to set up over 100 in-school clinics.